These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7064152

  • 1. Nephrotoxicity of the flame retardant, tris(2,3-dibromopropyl) phosphate, and its metabolites.
    Elliott WC, Lynn RK, Houghton DC, Kennish JM, Bennett WM.
    Toxicol Appl Pharmacol; 1982 Jan; 62(1):179-82. PubMed ID: 7064152
    [No Abstract] [Full Text] [Related]

  • 2. Metabolism, distribution, and excretion of the flame retardant, tris(2,3-dibromopropyl) phosphate (tris-bp) in the rat: identification of mutagenic and nephrotoxic metabolites.
    Lynn RK, Garvie-Gould C, Wong K, Kennish JM.
    Toxicol Appl Pharmacol; 1982 Mar 30; 63(1):105-19. PubMed ID: 7071866
    [No Abstract] [Full Text] [Related]

  • 3. Species differences in kidney toxicity and metabolic activation of tris(2,3-dibromopropyl)phosphate.
    Søderlund EJ, Nelson SD, von Bahr C, Dybing E.
    Fundam Appl Toxicol; 1982 Mar 30; 2(4):187-94. PubMed ID: 7185616
    [No Abstract] [Full Text] [Related]

  • 4. Comparative genotoxicity studies of the flame retardant tris(2,3-dibromopropyl)phosphate and possible metabolites.
    Holme JA, Søderlund EJ, Hongslo JK, Nelson SD, Dybing E.
    Mutat Res; 1983 Dec 30; 124(3-4):213-24. PubMed ID: 6686285
    [Abstract] [Full Text] [Related]

  • 5. Mutagenicity and nephrotoxicity of two tris (2,3-dibromopropyl)-phosphate analogues: bis (2,3-dibromopropyl) phosphate and 2,3-dibromopropylphosphate.
    Søderlund E, Nelson SD, Dybing E.
    Acta Pharmacol Toxicol (Copenh); 1982 Jul 30; 51(1):76-80. PubMed ID: 7124413
    [No Abstract] [Full Text] [Related]

  • 6. Comparative genotoxicity and nephrotoxicity studies of the two halogenated flame retardants tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl)phosphate.
    Søderlund EJ, Dybing E, Holme JA, Hongslo JK, Rivedal E, Sanner T, Nelson SD.
    Acta Pharmacol Toxicol (Copenh); 1985 Jan 30; 56(1):20-9. PubMed ID: 3883695
    [Abstract] [Full Text] [Related]

  • 7. Structure-activity studies on the mutagenicity of tris(2,3-dibromopropyl) phosphate (Tris-BP) and its metabolites in Salmonella.
    Zeiger E, Pagano DA, Nomeir AA.
    Environ Mutagen; 1982 Jan 30; 4(3):271-7. PubMed ID: 7094911
    [Abstract] [Full Text] [Related]

  • 8. Comparative studies on nephrotoxic effects of tris (2,3-dibromopropyl) phosphate and bis (2,3-dibromopropyl) phosphate on rat urinary metabolites.
    Fukuoka M, Takahashi T, Naito K, Takada K.
    J Appl Toxicol; 1988 Feb 30; 8(1):43-52. PubMed ID: 3356864
    [Abstract] [Full Text] [Related]

  • 9. Another flame retardant, tris-(1,3-dichloro-2-propyl)-phosphate, and its expected metabolites are mutagens.
    Gold MD, Blum A, Ames BN.
    Science; 1978 May 19; 200(4343):785-7. PubMed ID: 347576
    [Abstract] [Full Text] [Related]

  • 10. Nephrotoxicity of the flame retardant tris(2,3-dibromopropyl)phosphate.
    Dybing E, Søderlund E.
    Arch Toxicol Suppl; 1980 May 19; 4():219-22. PubMed ID: 6933906
    [Abstract] [Full Text] [Related]

  • 11. Metabolic activation of bromopropyl compounds.
    Dybing E, Söderlund EJ, Nelson SD.
    Adv Exp Med Biol; 1981 May 19; 136 Pt A():647-54. PubMed ID: 7046380
    [No Abstract] [Full Text] [Related]

  • 12. Nephrotoxicity and hepatotoxicity of tris(2,3-dibromopropyl)phosphate in the rat.
    Söderlund E, Dybing E, Nelson SD.
    Toxicol Appl Pharmacol; 1980 Nov 19; 56(2):171-81. PubMed ID: 7466817
    [No Abstract] [Full Text] [Related]

  • 13. Nephrotoxic effect of tris(2,3-dibromopropyl)phosphate on rat urinary metabolites: assessment from 13C-NMR spectra of urines and biochemical and histopathological examinations.
    Fukuoka M, Takahashi T, Tanaka A, Yamaha T, Naito K, Nakaji Y, Kobayashi K, Tobe M.
    J Appl Toxicol; 1987 Feb 19; 7(1):23-34. PubMed ID: 3611594
    [Abstract] [Full Text] [Related]

  • 14. Tris (2,3-dibromopropyl) phosphate nephrotoxicity in the rat: histological and biochemical changes in renal components by 13C-NMR spectra.
    Fukuoka M, Tanaka A, Yamaha T, Naito K, Takada K, Kobayashi K, Tobe M.
    J Appl Toxicol; 1988 Dec 19; 8(6):411-6. PubMed ID: 3230254
    [Abstract] [Full Text] [Related]

  • 15. Metabolism and disposition of the flame retardant tris(2,3-dibromopropyl)phosphate in the rat.
    Nomeir AA, Matthews HB.
    Toxicol Appl Pharmacol; 1983 Mar 15; 67(3):357-69. PubMed ID: 6845365
    [Abstract] [Full Text] [Related]

  • 16. A new mutagenic and genotoxic response of the flame retardant tris(2,3-dibromopropyl)phosphate. Activation by singlet oxygen.
    McCoy E, Hyman J, Rosenkranz HS.
    Mutat Res; 1980 Mar 15; 77(3):209-14. PubMed ID: 6991918
    [Abstract] [Full Text] [Related]

  • 17. Rat teratology study of orally administered tris-(2,3-dibromopropyl) phosphate.
    Seabaugh VM, Collins TF, Hoheisel CA, Bierbower GW, McLaughlin J.
    Food Cosmet Toxicol; 1981 Feb 15; 19(1):67-72. PubMed ID: 7262733
    [No Abstract] [Full Text] [Related]

  • 18. Activation mechanism of tris(2,3-dibromopropyl)phosphate to the potent mutagen, 2-bromoacrolein.
    Nelson SD, Omichinski JG, Iyer L, Gordon WP, Soderlund EJ, Dybing E.
    Biochem Biophys Res Commun; 1984 May 31; 121(1):213-9. PubMed ID: 6375666
    [Abstract] [Full Text] [Related]

  • 19. Tris(2-chloroethyl) phosphate.
    IARC Monogr Eval Carcinog Risks Hum; 1990 May 31; 48():109-20. PubMed ID: 2197455
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of oral administration of tris(2-chloroethyl) phosphate to pregnant rats on prenatal and postnatal development].
    Kawashima K, Tanaka S, Nakaura S, Nagao S, Endo T, Onoda K, Takanaka A, Omori Y.
    Eisei Shikenjo Hokoku; 1983 May 31; (101):55-61. PubMed ID: 6675772
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.